Traini, Enea

Cholinergic precursors in the treatment of cognitive impairment of vascular origin: Ineffective approaches or need for re-evaluation?

Parnetti, L., Mignini, F., Tomassoni, D., Traini, E., & Amenta, F. (2007) · Journal of the Neurological Sciences

Neuroprotection in Cerebral IschemiaDementia and Cognitive Impairment Research

Cited by 122

Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.

Traini, E., Bramanti, V., & Amenta, F. (2013) · Current Alzheimer Research

Neuroprotection in Cerebral IschemiaCholinesterase and Neurodegenerative Diseases

Cited by 78

The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer’s disease with cerebrovascular injury: interim results.

Amenta, F., Carotenuto, A., Fasanaro, A. M., Rea, R., & Traini, E. (2012) · Journal of the Neurological Sciences

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 52

The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer’s Disease) trial: interim results after two years of treatment.

Amenta, F., Carotenuto, A., Fasanaro, A. M., Rea, R., & Traini, E. (2014) · Journal of Alzheimer s Disease

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 50

Late and early onset dementia: What is the role of vascular factors? A retrospective study

Carotenuto, A., Rea, R., Colucci, L., Ziello, A. R., Molino, I., Carpi, S., Traini, E., Amenta, F., & Fasanaro, A. M. (2012) · Journal of the Neurological Sciences

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 27